ch.oddb.org 
German | English | French
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Remsima 350 mg, solution à diluer pour perfusion - 
70236002 iQone Healthcare Switzerland SA
Remsima 350 mg, solution à diluer pour perfusion03.07.2026
Generic06.07.2026
Infliximab (L04AB02) 
WHO-DDD02.07.2031
70000. 
07.15. 
A  
Yes 
IP 
1735.34Yes
    
10 %1903.70
7680702360027Biotechnologika
  
Composition
infliximabum 350 mg, acidum aceticum, natrii acetas trihydricus corresp. natrium max. 2.20 mg, sorbitolum 393.8 mg, polysorbatum 80 4.4 mg, aqua ad iniectabile ad solutionem pro 8.75 ml.
Packungsbestandteile
Concentrate for infusion 
  
 
Active AgentDose
Infliximab350mg / 8.75ml
BAG: Active Agent
Infliximab
 
Inactive agentsDose
Acetic Acid 
Natrii Acetas Trihydricus 
Polysorbatum 804.4mg / 8.75ml
Sorbitol393.8mg / 8.75ml
 
Source
Data was imported : 06.08.2026 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home